New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Akari Therapeutics Closes $75 Million Private Placement
-
Celsus Therapeutics (CLTX) Closes Acquisition of Volution Immuno Pharma
-
Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce Completion of Acquisition and Formation of Complement C5 Inhibitor Company Akari Therapeutics Plc
-
LearnUp Announces $8M Series A Funding to Train America's Entry-level Job Seekers at Scale
-
California Credit Union Bringing EverFi Financial Literacy Platform to Los Angeles County High Schools
-
NEA Names Stephen Oesterle As Venture Partner
-
NEA Names Stephen Oesterle As Venture Partner
-
Philo Now Available at 40+ Universities Nationwide
-
Console Inc. Announces Console(TM) Partner Programs
-
One Source Networks Joins Console NSP Partner Program
-
iTel Networks Inc. to Offer Direct Access to Console's Software and Interconnection Platform
-
Zayo Group Joins the Console NSP Partner Program
-
ScaleMatrix to Enhance Hybrid Service Offer by Enabling Direct Access to Console's Software and Interconnection Platform
-
VeloCloud to Offer Direct Access to Console's Software and Interconnection Platform
-
Microsoft Azure ExpressRoute Available on Console
-
BTI Systems Joins Console's Technology Partner Program
-
Netelligent to Offer Direct Access to Console's Software and Interconnection Platform
-
Proteostasis Therapeutics, Inc. Raises $37 Million in Crossover Financing
-
Console Connect LIVE 2015 Includes Leading Speakers and Prime Sponsors
-
Placester Launches Plans to Help Real Estate Agents Convert Leads
-
Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit
-
MACH37™ Cyber Accelerator Announces New Funding for Two Program Graduates, Virgil Security and Cyph
-
Placester Headcount Increases 80 Percent in Four-Month Span
-
Education startup HotChalk in talks to raise new funding: sources
-
U.S. Renal Care and DSI Renal Announce Definitive Merger Agreement
-
Global Genes Announces Celebrities, Iconic Athletes and Pop Stars Joining the Fourth Annual RARE Tribute to Champions of Hope Gala
-
Spare5 Raises $10 Million from Foundry Group, Madrona Venture Group and New Enterprise Associates to Turn Big Data into Micro-Tasks
-
Coursera Secures $49.5M in Series C Funding to Expand Access to Job-Relevant Learning Opportunities From the World's Best Universities
-
Ideel Selects Blueshift to Power Multi-Channel Customer Engagement
-
Uber seen reaching $10.8 billion in bookings in 2015: fundraising presentation
-
Unusual 11 Mid-Day Movers 8/19: (CLTX) (HILL) (ACI) Higher; (RYAM) (TEDU) (FLXS) Lower
-
Celsus Therapeutics (CLTX), Volution Immuno Announce $75M Private Placement
-
Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce $75 Million Private Placement
-
Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing
-
Suniva to Increase U.S. Manufacturing Capacity to Over 400MW
-
Vtesse, Inc. Announces Preliminary Data from Ongoing Phase 1 Study of VTS-270 for Treatment of Niemann-Pick Disease Type C
-
BioHealth Innovation's Relevant Health Accelerator Recognized As One Of The Nation's Leading Startup Accelerators By The U.S. Small Business Administration
-
Tintri Raises $125 Million in Financing to Accelerate Global Adoption of VM-Aware Storage
-
IIX Revolutionizes Enterprise Direct Connect With the Launch of Console Inc.
-
Ra Pharmaceuticals Announces $58.5M Series B Financing
-
Apprenda Raises $24M from Safeguard Scientifics, New Enterprise Associates and Ignition Partners
-
Ziarco Appoints Mike Grey as Executive Chairman of Board of Directors
-
Global Genes Announces Fourth Annual RARE Tribute to Champions of Hope Award Recipients
-
Form SC 13D/A Vitae Pharmaceuticals, Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
CIT GAP Funds Invests in PockitShip
-
Allergan to Acquire Oculeve Dry Eye Disease Development Programs
-
Form 4 Vitae Pharmaceuticals, For: Jul 01 Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Cortendo AB: Cortendo Provides 2015 Half-Year Update on Corporate Progress
-
CIT GAP Funds Invests in TypeZero Technologies
-
ESSA Pharma Inc. Announces Appointment of New Director

